BioSpace News Archive

Nautilus Biotechnology, Inc., a company pioneering a single molecule proteome analysis platform, reported financial results for the third quarter ended September 30, 2022.

Human Immunology Biosciences, a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases, announced its launch with $120 million in financing.

United Therapeutics Corporation announced that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s business during a fireside chat session at the Credit Suisse 31st Annual Healthcare Conference in Los Angeles.

Pyxis Oncology, Inc. reported financial results for the third quarter and nine months ended September 30, 2022 and provided a corporate update.

Karuna Therapeutics, Inc. announced that Troy Ignelzi, chief financial officer of Karuna Therapeutics, will participate in a fireside chat at the Jefferies 2022 London Healthcare Conference on Wednesday, November 16, 2022, at 3:50 p.m. GMT.

OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2022 third quarter financial results and certain business developments for 5:00 pm ET on Tuesday, November 8, 2022.

Rezolute, Inc. announced that Nevan Charles Elam, Chief Executive Officer and Founder, will participate in a fireside chat at the Jefferies London Healthcare Conference on Thursday, November 17, 2022, at 11:25 a.m. EST/4:25 p.m. GMT.

Xeris Biopharma Holdings, Inc. today announced that the European Journal of Endocrinology (EJE) published the extended evaluation (EE) results of the SONICS study (NCT01838551) evaluating longer-term effects of levoketoconazole on cortisol levels, biomarkers of Cushing’s syndrome (CS) comorbidities.

CareDx, Inc. today announced the results of a new study published in the Clinical Journal of the American Society of Nephrology (CJASN)1 showing that CareDx’s AlloSure® Kidney donor-derived cell-free DNA (dd-cfDNA) solution identifies early signs of allograft rejection and BK virus infection in pediatric kidney transplant patients.

Topline data show positive signal in treating excessive daytime sleepiness.